This unbalanced exchange of blood is associated with the characteristic clinical findings of volume overload in the recipient twin, volume depletion in the donor twin, and discordant fetal growth. 7 Although it is known that monochorionic diamniotic twin pregnancies are at an increased risk of congenital anomalies, the rate of such anomalies in the setting of twintwin transfusion syndrome is unknown. It has previously been suggested that cardiac anomalies in the setting of twin-twin transfusion syndrome may be the result of altered blood flow patterns seen in each twin. [8] [9] [10] This factor makes it difficult to identify which cardiac anomalies are intrinsic in nature and which are the result of the hemodynamic changes associated with twin-twin transfusion syndrome. Noncardiac structural anomalies in the setting of twin-twin transfusion syndrome have been reported in only a few studies and case reports. 11, 12 We performed a literature search using the search engines Ovid and PubMed; both databases were searched using the phrases and words "twin-twin transfusion syndrome," "twin-twin transfusion," "congenital," "anomalies," "noncardiac," "donor," and "recipient." To the best of our knowledge, there are no studies in the literature that describe either the prevalence of noncardiac structural anomalies seen in the setting of twin-twin transfusion syndrome or the rate of donor versus recipient anomalies.
The objective of this study was to describe the noncardiac congenital anomalies seen in twins who underwent laser surgery for twin-twin transfusion syndrome and to determine the rates of these anomalies in donor and recipient twins.
Materials and Methods
A retrospective study was conducted of 221 consecutive cases of twin-twin transfusion syndrome treated with laser surgery at the Los Angeles Fetal Therapy Program of the University of Southern California between March 2006 and May 2010. All fetuses with an intrauterine fetal demise were excluded because a postnatal examination to confirm the presence or absence of anomalies was not possible. Each set of twins underwent detailed preoperative and postoperative fetal anatomy sonographic examinations. All patients then returned to their referring physicians to be subsequently treated and delivered. Information prospectively recorded for each case included maternal demographics (age, gravida, and para), the Quintero stage of twin-twin transfusion syndrome, 7 intrauterine growth restriction of the donor twin, estimated gestational age at diagnosis and at laser surgery, estimated gestational age at delivery, and perinatal survival at 30 days. Laser surgery was performed using techniques described previously. 13 Umbilical cord occlusion for twin-twin transfusion syndrome is not a treatment option at our institution.
A thorough review of all sonographic reports, dictated surgical reports, placental pathologic reports, and neonatal records for each twin was conducted. All noncardiac anomalies diagnosed via prenatal sonography were confirmed by review of neonatal records. A noncardiac anomaly was defined as an abnormality involving any organ system other than the heart. All cardiac anomalies were excluded because of known secondary cardiac derangements that arise in association with twin-twin transfusion syndrome. All noncardiac anomalies were classified as major or minor according to the Western Australian Birth Defects Registry system. 14 Congenital anomalies not listed in the registry were classified at the discretion of the pediatric geneticist (L.M.R.). The number of anomalies reported in this study refers to the number of live-born neonates with noncardiac structural anomalies. Patient characteristics and perinatal outcomes of the first 210 pregnancies in this study have been described previously. 13 Statistical analyses were performed at the level of the neonate using Fisher exact and χ 2 tests. P < .05 was considered statistically significant.
Results
The antepartum and neonatal records of 221 consecutive cases of twin-twin transfusion syndrome gestations treated with laser surgery were reviewed. Of these gestations, 11 had an intrauterine fetal demise of both fetuses, 43 had an intrauterine fetal demise of 1 fetus, and 167 had no intrauterine fetal demise, yielding 377 live-born fetuses in 210 gestations as our final study population ( Figure 1 ). Of these live-born fetuses, noncardiac congenital anomalies were identified in a total of 19 individual twins (5.0%; Table 1 ). None of the pregnancies had more than one fetus with an anomaly. The rate of noncardiac congenital anomalies was increased for donor versus recipient twins (15 of 177 [8.5%] versus 4 of 200 [2.0%]; P < .01). Of the 15 donor twins with anomalies, 11 had major anomalies; all 4 of the recipient twins with anomalies had major anomalies. The prevalence of major noncardiac anomalies did not differ statistically between donors and recipients (11 of 177 [6.2%] versus 4 of 200 [2.0%]; P = .061). During the antenatal period, anomalies were detected on sonography in 5 donor twins (33.3%). In the recipient twins, none of the anomalies were identified during the antenatal period. We found multiple cases of 6 different types of anomalies ( Nine fetuses with a diagnosis of an anomaly during the antenatal period were excluded from the study because of an intrauterine fetal demise. Eight of these fetuses were donor twins, and 1 was a recipient twin. Table 3 provides a description of these fetuses, including the types of anomalies, Quintero stage, gestational age at diagnosis, gestational age at delivery, and survival of the cotwin. 
Discussion
In this retrospective study of 221 consecutive cases of twintwin transfusion syndrome treated with laser surgery, we found that the prevalence of noncardiac congenital anomalies in live-born fetuses (5.0%) was similar to the rate of noncardiac anomalies reported for all monochorionic twins in general (4.3%). 15 However, we found that the rate of noncardiac anomalies was not the same between donor twins and recipient twins but, rather, that donor twins had a statistically higher rate of anomalies. The etiology for the relatively higher rate of donor noncardiac anomalies (8.5%) versus recipient noncardiac anomalies (2.0%) is unknown but may be partially explained by inherent inequities in the twinning process, which in turn may lead to the development of twin-twin transfusion syndrome. It has been suggested that unequal division of the inner embryonic cells of a blastocyst may lead to delayed cardiac development of the twin with fewer cells and a resulting blood pressure disparity, leading to differential vascular development of the placenta. 16 It is possible that this unequal sharing of embryonic cells may predispose the fetus with fewer cells to noncardiac anomalies.
Impaired perfusion to the donor twin may also play a role in the development of noncardiac anomalies in twintwin transfusion syndrome. Vascular mechanisms have been proposed to be involved in the pathogenesis of several birth defects, resulting in interference with basic developmental events, leading to apoptosis and thence to congenital anomalies. 17 Multiple animal models of mice, rats, and rabbits have shown the teratogenic effects of hypoxia in early pregnancy. Fetuses of pregnant mice in a highaltitude simulated model showed central nervous system, facial, and genitourinary system anomalies. 18 Maternal rats with anemia gave birth to pups with central nervous system, limb, and ophthalmologic anomalies. 18 Although these animal models of early hypoxia and impaired perfusion have shown increased rates of congenital anomalies, it is unclear whether these animal models accurately replicate the conditions found in twin-twin transfusion syndrome. Although no studies have been done showing donor or recipient twin hypoxia, there is literature evidence of abnormal fetal Doppler measurements (umbilical artery and middle cerebral artery) in the setting of decreased fetal oxygen saturation. 19 In this study, there was no correlation between abnormal fetal Doppler measurements and noncardiac anomalies. Our study had several strengths. To our knowledge, a study describing the prevalence of noncardiac structural anomalies in fetuses with twin-twin transfusion syndrome who underwent laser surgery has not been reported previously. We were also able to link prenatal and postnatal data for donor-recipient pairs. Furthermore, the large sample size made statistical testing feasible for the comparison of donor and recipient twins.
The most important weakness of our study was the selection bias that occurred because of fetal loss. Those fetuses who died before birth could not be thoroughly examined for anomalies. It appears that the rate of anomalies detected among those with intrauterine fetal demise (9 of 65 [13.8%]) was higher than that among those fetuses who were live born (19 of 377 [5.0%]), suggesting that the prevalence of anomalies in all fetuses with twin-twin transfusion syndrome, if we had been able to evaluate it, would likely have been higher than our estimate for live-born patients only. Further underestimation of the prevalence rate of anomalies also may have occurred because our institution does not offer umbilical cord occlusion for twin-twin transfusion syndrome, and those patients with an anomalous twin and twin-twin transfusion syndrome desiring selective reduction may have been referred to another fetal treatment center. Patients who already had a loss of one or both fetuses would also be excluded from undergoing laser surgery and would not be referred for that treatment. Thus, we could not assess the rate of anomalies in monochorionic diamniotic gestations with twin-twin transfusion syndrome but, rather, only the rate of anomalies in live-born neonates. This exclusion likely yielded a lower rate of anomalies, as evidenced by the fact that a noncardiac anomaly was diagnosed antenatally in 9 of 65 cases of intrauterine fetal demise (Table 3) .
Second, the study was limited by the use of record review (neonatal records were from multiple centers) because the fetuses and neonates were not available for examination. This factor again may have led to an underestimation because some anomalies may have been missed with lack of a standardized protocol for neonatal evaluation and documentation of findings.
Last, because every patient in this study underwent laser surgery, this study may have included fetuses who had procedure-related complications. One case report in the literature did describe intestinal atresia developing in the recipient twin after laser surgery. 20 However, the other congenital anomalies identified in this study cannot be readily explained as complications of laser surgery, and our study cannot determine whether a congenital anomaly is the effect of twin-twin transfusion syndrome.
To our knowledge, a study describing the prevalence of noncardiac structural anomalies in fetuses with twintwin transfusion syndrome who underwent laser surgery has not been reported previously. We found that the donor twins had a higher rate of noncardiac anomalies compared to the recipient twins. Although the causes of these anomalies are presently unknown, inherent inequities in the twinning process, abnormal tissue perfusion, and tissue hypoxia may all have a part in the process.
